140 related articles for article (PubMed ID: 19725224)
41. Myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis.
Tanyeli A; Erbey F; Bayram I; Kömür M
Asian Pac J Cancer Prev; 2010; 11(6):1823-6. PubMed ID: 21338240
[TBL] [Abstract][Full Text] [Related]
42. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13.
Nishii K; Kita K; Miwa H; Kawakami K; Nakase K; Masuya M; Morita N; Omay SB; Otsuji N; Fukumoto M
Leukemia; 1992 Jul; 6(7):662-8. PubMed ID: 1378163
[TBL] [Abstract][Full Text] [Related]
43. Expression of CD15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type.
Lenkei R; Björk O; Ost A; Biberfeld P
Leuk Res; 1991; 15(4):189-94. PubMed ID: 1674292
[TBL] [Abstract][Full Text] [Related]
44. Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.
Piccaluga PP; Arpinati M; Candoni A; Laterza C; Paolini S; Gazzola A; Sabattini E; Visani G; Pileri SA
Leuk Lymphoma; 2011 Feb; 52(2):325-7. PubMed ID: 21077738
[No Abstract] [Full Text] [Related]
45. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
46. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
Sahu GR; Das BR
Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
[TBL] [Abstract][Full Text] [Related]
48. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
Akahane K; Inukai T; Inaba T; Kurosawa H; Look AT; Kiyokawa N; Fujimoto J; Goto H; Endo M; Zhang X; Hirose K; Kuroda I; Honna H; Kagami K; Goi K; Nakazawa S; Sugita K
Leukemia; 2010 Apr; 24(4):865-9. PubMed ID: 20147975
[No Abstract] [Full Text] [Related]
49. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
50. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
51. Hand mirror variant of adult acute lymphoblastic leukemia. Evidence for a mixed leukemia.
Kovarik P; Shrit MA; Yuen B; Radvany R; Schumacher HR
Am J Clin Pathol; 1992 Nov; 98(5):526-30. PubMed ID: 1283057
[TBL] [Abstract][Full Text] [Related]
52. Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia.
Howard MR; Thomas L; Reid MM
J Clin Pathol; 1994 Nov; 47(11):1006-9. PubMed ID: 7829673
[TBL] [Abstract][Full Text] [Related]
53. Adult precursor T-lymphoblastic leukemia/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy.
Al Khabori M; Samiee S; Fung S; Xu W; Brandwein J; Patterson B; Brien W; Chang H
Acta Haematol; 2008; 120(1):5-10. PubMed ID: 18635939
[TBL] [Abstract][Full Text] [Related]
54. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
55. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract][Full Text] [Related]
56. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
57. Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.
Dinndorf PA; Buckley JD; Nesbit ME; Lampkin BC; Piomelli S; Feig SA; Kersey JH; Hammond GD; Bernstein ID
Med Pediatr Oncol; 1992; 20(3):192-200. PubMed ID: 1574028
[TBL] [Abstract][Full Text] [Related]
58. [Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].
Ma J; Liu YF; Chen SM; Zhang QT; Sun L; Liu LX; Wan DM; Chen SQ; Xie XS; Meng XL; Jiang ZX; Cheng YD; Wang F; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):942-5. PubMed ID: 20723305
[TBL] [Abstract][Full Text] [Related]
59. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts.
Baruchel A; Cayuela JM; Ballerini P; Landman-Parker J; Cezard V; Firat H; Haddad E; Auclerc MF; Valensi F; Cayre YE; Macintyre EA; Sigaux F
Br J Haematol; 1997 Oct; 99(1):101-6. PubMed ID: 9359509
[TBL] [Abstract][Full Text] [Related]
60. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
